2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2022
JOURNALPharmaceutics
PREMIER AUTEURLaures N
TITREImpact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis.
ANNÉE2022
JOURNALPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology
PREMIER AUTEURLioret V
TITREWater soluble octa-imidazolium zinc phthalocyanine for nucleus/nucleolus cell fluorescence microscopy and photodynamic therapy.
ANNÉE2022
JOURNALCancers
PREMIER AUTEURToussaint K
TITRENeuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases.
ANNÉE2022
JOURNALJAMA network open
PREMIER AUTEURReboux N
TITREIncidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
ANNÉE2022
JOURNALJournal of gastrointestinal oncology
PREMIER AUTEURLongo R
TITREA fatal primary gastric melanoma treated by a double immunotherapy with ipilimumab/nivolumab: description of a case report.
ANNÉE2022
JOURNALJournal for immunotherapy of cancer
PREMIER AUTEURWislez M
TITRENeoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
ANNÉE2022
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURBoustani J
TITRE[Dose-escalated radiotherapy in esophageal cancer: A review of the literature].
ANNÉE2022
JOURNALBMJ open
PREMIER AUTEURAssogba ELF
TITRECross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.
ANNÉE2022
JOURNALFrontiers in cardiovascular medicine
PREMIER AUTEURJacquinot Q
TITRECardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab.
ANNÉE2022
JOURNALBiomaterials science
PREMIER AUTEURKalot G
TITRELipoprotein interactions with water-soluble NIR-II emitting aza-BODIPYs boost the fluorescence signal and favor selective tumor targeting.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques